OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of the American Society of Nephrology is 51. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Kidney Outcomes in Long COVID	223
A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease	186
New ‘Antigens’ in Membranous Nephropathy	155
Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients	154
Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology	153
COVID-19–Associated Glomerular Disease	146
Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients	142
Modifiable Lifestyle Factors for Primary Prevention of CKD: A Systematic Review and Meta-Analysis	141
A Comprehensive Map of mRNAs and Their Isoforms across All 14 Renal Tubule Segments of Mouse	133
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial	123
Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study	115
A Randomized Clinical Trial of Anti–IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection	114
Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial	110
Deep Learning–Based Segmentation and Quantification in Experimental Kidney Histopathology	109
Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study	108
Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial	108
Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease	107
Incidence, Characteristics, and Outcome of COVID-19 in Adults on Kidney Replacement Therapy: A Regionwide Registry Study	107
Protocadherin 7–Associated Membranous Nephropathy	106
Prevalence Estimates of Predicted Pathogenic COL4A3–COL4A5 Variants in a Population Sequencing Database and Their Implications for Alport Syndrome	100
Mechanisms and Models of Kidney Tubular Necrosis and Nephron Loss	96
Exploring the Complexity of Death-Censored Kidney Allograft Failure	94
B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients	84
Spatially Resolved Transcriptomic Analysis of Acute Kidney Injury in a Female Murine Model	80
A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney Organoids	80

Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis	77
Targeted Single-Cell RNA-seq Identifies Minority Cell Types of Kidney Distal Nephron	77
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial	76
Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study	74
Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study	73
The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies	73
Urinary Single-Cell Profiling Captures the Cellular Diversity of the Kidney	70
Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy	66
Long-Term Exposure to Ambient PM2.5 and Increased Risk of CKD Prevalence in China	62
Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report from the NKF-ASN Task Force	61
Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy	60
Comparing Approaches to Normalize, Quantify, and Characterize Urinary Extracellular Vesicles	60
Empagliflozin Inhibits Proximal Tubule NHE3 Activity, Preserves GFR, and Restores Euvolemia in Nondiabetic Rats with Induced Heart Failure	60
In Patients with Membranous Lupus Nephritis, Exostosin-Positivity and Exostosin-Negativity Represent Two Different Phenotypes	59
Automated Computational Detection of Interstitial Fibrosis, Tubular Atrophy, and Glomerulosclerosis	59
Hematopoietic Stem Cell Transplant-Membranous Nephropathy Is Associated with Protocadherin FAT1	59
Management of Obesity in Adults with CKD	59
Mendelian Randomization Analysis as a Tool to Gain Insights into Causes of Diseases: A Primer	59
Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD	56
Association of Clonal Hematopoiesis of Indeterminate Potential with Worse Kidney Function and Anemia in Two Cohorts of Patients with Advanced Chronic Kidney Disease	56
Progressive Cellular Senescence Mediates Renal Dysfunction in Ischemic Nephropathy	55
Kim-1 Targeted Extracellular Vesicles: A New Therapeutic Platform for RNAi to Treat AKI	55
Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection	55
Missing Self-Induced Activation of NK Cells Combines with Non-Complement-Fixing Donor-Specific Antibodies to Accelerate Kidney Transplant Loss in Chronic Antibody-Mediated Rejection	55
Defects in KCNJ16 Cause a Novel Tubulopathy with Hypokalemia, Salt Wasting, Disturbed Acid-Base Homeostasis, and Sensorineural Deafness	53
Failure to Advance Access to Kidney Transplantation over Two Decades in the United States	52
Optimal Phosphate Control Related to Coronary Artery Calcification in Dialysis Patients	51